{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:29:58Z","timestamp":1793723398960,"version":"4.6.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.farma.2026.04.019","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:14:48Z","timestamp":1789244088000},"page":"T412-T417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["[Translated article] Role of the pharmacist in antimicrobial stewardship programs in critically ill patients"],"prefix":"10.1016","volume":"50","author":[{"given":"Miguel \u00c1ngel","family":"Amor Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Aquerreta Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Bastida Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaia","family":"Eg\u00fc\u00e9s Lugea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cobo Sacrist\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Becerril Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Mart\u00edn-Cerezuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Domingo Chiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Betancor Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Albanell Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Dom\u00e9nech-Moral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ortiz P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Fern\u00e1ndez Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.farma.2026.04.019_bb0005","doi-asserted-by":"crossref","first-page":"22.e1","DOI":"10.1016\/j.eimc.2011.09.018","article-title":"Programas de optimizaci\u00f3n de uso de antimicrobianos (PROA) en hospitales espa\u00f1oles: Documento de consenso GEIH-SEIMC, SEFH y SEMPSPH","volume":"30","author":"Rodr\u00edguez-Ba\u00f1o","year":"2012","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"3","key":"10.1016\/j.farma.2026.04.019_bb0010","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jointm.2022.10.001","article-title":"Antimicrobial stewardship in the intensive care unit","volume":"3","author":"Ture","year":"2023","journal-title":"J Intensive Med"},{"issue":"2","key":"10.1016\/j.farma.2026.04.019_bb0015","first-page":"99","article-title":"Antimicrobial stewardship programs in the intensive care unit in patients with infections caused by multidrug-resistant gram-negative bacilli","volume":"47","author":"Ruiz-Ramos","year":"2023","journal-title":"Med Intensiva (Engl Ed)"},{"key":"10.1016\/j.farma.2026.04.019_bb0020","series-title":"Antimicrobial resistance in the EU\/EEA (EARS-Net) \u2013 annual epidemiological report for 2024","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2025"},{"issue":"3","key":"10.1016\/j.farma.2026.04.019_bb0025","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/antibiotics13030238","article-title":"Bacterial infections in intensive care units: epidemiological and microbiological aspects","volume":"13","author":"Calvo","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.farma.2026.04.019_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhin.2025.01.015","article-title":"Meta-analysis of risk factors for infection by multi-drug-resistant organisms in intensive care unit patients","volume":"158","author":"Ye","year":"2025","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.farma.2026.04.019_bb0035","series-title":"Informe ENVIN-HELICS 2024. Estudio nacional de vigilancia de infecci\u00f3n nosocomial en servicios de medicina intensiva","author":"Grupo de Trabajo de Enfermedades Infecciosas y Sepsis","year":"2024"},{"issue":"3","key":"10.1016\/j.farma.2026.04.019_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19031039","article-title":"Risk factors for multidrug-resistant gram-negative bacteria carriage upon admission to the intensive care unit","volume":"19","author":"Fern\u00e1ndez-Mart\u00ednez","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"10.1016\/j.farma.2026.04.019_bb0045","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/ACO.0000000000000830","article-title":"Multidrug-resistant bacteria in ICU: fact or myth","volume":"33","author":"De Waele","year":"2020","journal-title":"Curr Opin Anaesthesiol"},{"issue":"15","key":"10.1016\/j.farma.2026.04.019_bb0050","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/jama.2020.2717","article-title":"Prevalence and outcomes of infection among patients in intensive care units in 2017","volume":"323","author":"Vincent","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.farma.2026.04.019_bb0055","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/CCM.0b013e3181961bff","article-title":"Pharmacokinetic issues for antibiotics in the critically ill patient","volume":"37","author":"Roberts","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.farma.2026.04.019_bb0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2014.07.006","article-title":"The effect of pathophysiology on pharmacokinetics in the critically ill patient \u2013 concepts appraised by the example of antimicrobial agents","volume":"77","author":"Blot","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10.1016\/j.farma.2026.04.019_bb0065","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper#","volume":"46","author":"Abdul-Aziz","year":"2020","journal-title":"Intensive Care Med"},{"issue":"12","key":"10.1016\/j.farma.2026.04.019_bb0070","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/0885066618762747","article-title":"Antibiotic use in the intensive care unit: optimization and de-escalation","volume":"33","author":"Campion","year":"2018","journal-title":"J Intensive Care Med"},{"issue":"10","key":"10.1016\/j.farma.2026.04.019_bb0075","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s00134-022-06847-2","article-title":"Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing software","volume":"48","author":"Roberts","year":"2022","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.farma.2026.04.019_bb0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S2468-1253(16)30119-4","article-title":"The role of the gut microbiota in sepsis","volume":"2","author":"Haak","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.farma.2026.04.019_bb0085","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s13054-022-04127-5","article-title":"The central and biodynamic role of gut microbiota in critically ill patients","volume":"26","author":"Wozniak","year":"2022","journal-title":"Crit Care"},{"issue":"8","key":"10.1016\/j.farma.2026.04.019_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/diseases13080250","article-title":"Host-microbiome interaction in the intensive care unit","volume":"13","author":"Neag","year":"2025","journal-title":"Diseases"},{"issue":"11","key":"10.1016\/j.farma.2026.04.019_bb0095","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1016\/S1473-3099(17)30304-3","article-title":"Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer","volume":"17","author":"Colombo","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.farma.2026.04.019_bb0100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.eimc.2022.05.005","article-title":"Antimicrobial stewardship in hospitals: expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP","volume":"41","author":"Cercenado","year":"2023","journal-title":"Enferm Infecc Microbiol Clin (Engl Ed)"},{"issue":"10","key":"10.1016\/j.farma.2026.04.019_bb0115","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/phar.2850","article-title":"Utility of triazole antifungal therapeutic drug monitoring: insights from the society of infectious diseases pharmacists: endorsed by the mycoses study group education and research consortium","volume":"43","author":"McCreary","year":"2023","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.farma.2026.04.019_bb0120","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.mcna.2018.05.009","article-title":"Role of the pharmacist in antimicrobial stewardship","volume":"102","author":"Parente","year":"2018","journal-title":"Med Clin N Am"},{"issue":"2","key":"10.1016\/j.farma.2026.04.019_bb0105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/cid\/ciu747","article-title":"Quality indicators to measure appropriate antibiotic use in hospitalized adults","volume":"60","author":"van den Bosch","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.farma.2026.04.019_bb0110","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.farma.2026.04.019_bb0160","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40506-014-0015-3","article-title":"Antimicrobial stewardship programs: appropriate measures and metrics to study their impact","volume":"6","author":"Morris","year":"2014","journal-title":"Curr Treat Opt Infect Dis"},{"issue":"4","key":"10.1016\/j.farma.2026.04.019_bb0125","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01825-17","article-title":"A before-and-after study of the effectiveness of an antimicrobial stewardship program in critical care","volume":"62","author":"\u00c1lvarez-Lerma","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.farma.2026.04.019_bb0130","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/jac\/dkab034","article-title":"Quality indicators for hospital antimicrobial stewardship programmes: a systematic review","volume":"76","author":"O'Riordan","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.farma.2026.04.019_bb0135","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/cid\/ciw787","article-title":"Expert consensus on metrics to assess the impact of patient-level antimicrobial stewardship interventions in acute-care settings","volume":"64","author":"Moehring","year":"2017","journal-title":"CLINID"},{"issue":"6","key":"10.1016\/j.farma.2026.04.019_bb0140","doi-asserted-by":"crossref","first-page":"782.e1","DOI":"10.1016\/j.cmi.2019.10.021","article-title":"The effect of an antimicrobial stewardship programme in two intensive care units of a teaching hospital: an interrupted time series analysis","volume":"26","author":"Onorato","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.farma.2026.04.019_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207991","article-title":"Development of actionable quality indicators and an action implementation toolbox for appropriate antibiotic use at intensive care units: a modified-RAND Delphi study","volume":"13","author":"Kallen","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.farma.2026.04.019_bb0150","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jhin.2025.04.020","article-title":"A systematic review of antimicrobial stewardship interventions implemented in intensive care units","volume":"162","author":"Ntim","year":"2025","journal-title":"J Hosp Infect"},{"issue":"6","key":"10.1016\/j.farma.2026.04.019_bb0155","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper#","volume":"46","author":"Abdul-Aziz","year":"2020","journal-title":"Intensive Care Med"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634326001844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634326001844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:06:07Z","timestamp":1793721967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634326001844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1130634326001844"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2026.04.019","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Role of the pharmacist in antimicrobial stewardship programs in critically ill patients","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2026.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2026.04.014","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}